Clinical Trial

Bilateral Ultrasound Guided Superficial Parasternal Intercostal Plane Block Versus Erector Spinae Plane Block

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Group (A): This group will receive fentanyl infusion at a dose of (0.5μg/kg/h) all through the whole operation plus ultrasound guided bilateral superficial parasternal intercostal Plane block which will be done by injecting 0.4ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side3. Group (B): This group will receive fentanyl infusion at a dose of (0.5μg/kg/h) all through the whole operation plus Ultrasound guided bilateral ESPB which will be done by injecting 0.4ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side .
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-03.
Trial Details
NCT Number NCT06958120
Lead Sponsor Cairo University
Conditions CHD - Congenital Heart Disease
Enrollment 50 participants
Start Date 2025-06
Primary Completion 2025-12 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-05-13